{"id":555233,"date":"2021-07-29T19:04:01","date_gmt":"2021-07-29T19:04:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=555233"},"modified":"2021-07-29T19:04:01","modified_gmt":"2021-07-29T19:04:01","slug":"dermatomycoses-market-analysis-portrays-a-promising-outlook-of-the-emerging-drugs-during-the-forecast-period-202130","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/dermatomycoses-market-analysis-portrays-a-promising-outlook-of-the-emerging-drugs-during-the-forecast-period-202130_555233.html","title":{"rendered":"Dermatomycoses Market Analysis Portrays a Promising Outlook of the Emerging Drugs During the Forecast Period (2021-30)"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1627541532.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Dermatomycoses Market Analysis Portrays a Promising Outlook of the Emerging Drugs During the Forecast Period (2021-30)\" src=\"https:\/\/www.abnewswire.com\/uploads\/1627541532.png\" alt=\"Dermatomycoses Market Analysis Portrays a Promising Outlook of the Emerging Drugs During the Forecast Period (2021-30)\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>Dermatomycoses Market<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Increased awareness of this distinct histology has resulted in the development of drugs specific to dermatomycoses, as well as the beginning of shedding light on the similarities and potential differences.<\/div>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/uploads\/0bcb34a04d86de2aeac0cb8d9d6f516d.jpg\" alt=\"\" \/><\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>DelveInsight&#8217;s <\/span><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/dermatomycoses-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Dermatomycoses market report<\/a><\/strong><span> provides a comprehensive understanding of Dermatomycoses epidemiology, historical and forecasted epidemiology, and market trends in the 7MM (the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan). In addition, the report also covers current Dermatomycoses treatment practices\/algorithms, Dermatomycoses market drivers, Dermatomycoses market barriers, and unmet medical needs.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Some of the Key Highlights from the Dermatomycoses Market Report<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Dermatophytes cause the majority of fungal infections of the skin in <strong>Germany<\/strong> and around the world.<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Dermatomycoses, including dermatophytosis, are commonly seen in routine medical care, according to Mochizuki et al. (2019). In Japan, tinea pedis was estimated to affect <\/span><strong>21.6 percent<\/strong><span> of the population, while tinea unguium was estimated to affect <\/span><span>10.0 percent <\/span><span>of the population.<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Blueberry Therapeutics, Novan, <\/strong><span>and others are among the major companies which are developing novel therapies to boost the Dermatomycoses treatment outlook.<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Blueberry Therapeutics<\/strong><span> is developing <\/span><strong>BB2603<\/strong><span>, a first-in-class nano-formulation of the most effective antifungal agent currently on the market. It is intended to treat both onychomycosis and Tinea pedis at the same time. Currently, it is in Phase I\/II clinical trials for Dermatomycoses.&nbsp;<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span><strong>SB208<\/strong> <\/span><span>is being developed by <\/span><span><strong>Novan<\/strong> <\/span><span>as a broad-spectrum antifungal gel for the treatment of superficial cutaneous fungal infections of the skin and nails, such as tinea pedis and onychomycosis.<\/span><\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>To know more about the types of dermatomycoses, request sample @ <\/span><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/dermatomycoses-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Dermatomycoses Market Research<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>The Dermatomycoses market report<\/strong><span> also covers current treatment practices, emerging drugs, Dermatomycoses market share of individual therapies, as well as current and forecasted Dermatomycoses market Size from 2018 to 2030, segmented by seven major markets.&nbsp;<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Dermatomycoses: Overview<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>Dermatomycoses is the medical term for fungal infections of the skin and skin appendages, including nails and hair, caused most commonly by dermatophytes. Fungal infections can occur at any time and be caused due to injured or pathologically altered skin areas. Dermatophytes are classified as anthropophilic, zoophilic, or geophilic based on their mode of transmission and primary occurrence.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Dermatomycoses Epidemiology Segmentation<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>The Dermatomycoses report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Dermatomycoses Total Incidence\/Prevalence<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Dermatomycoses Total Cases<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>Dermatomycoses Diagnosed and Treatable Cases<\/span><\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Dermatomycoses Treatment Landscape<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>A wide variety of topical antimycotic agents such as <\/span><span>nystatin<\/span><span> and <\/span><span>amphotericin B, <\/span><span>and systemic antimycotic agents such as <\/span><span>Fluconazole and itraconazole <\/span><span>are available for the Dermatomycoses treatment.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>There are several FDA-approved drugs such as <\/span><strong>Efinaconazole, Luliconazole, Naftin, JUBLIA, <\/strong><span>and others that are used for Dermatomycoses treatment.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Dermatomycoses Market<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>Increased awareness of this distinct histology has resulted in the development of drugs that are specific to dermatomycoses and has begun to shed light on the similarities and potential differences. These factors, along with the anticipated launch of new therapies such as <\/span><span>SB208, BB2603, <\/span><span>and others, will drive the Dermatomycoses market size during the forecast period (2021-2030).<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Dermatomycoses Pipeline Therapies and Key Companies<\/strong><span>&nbsp;<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>SB208: Novan<\/span><\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><span>BB2603: Blueberry Therapeutics<\/span><\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>For more information on the emerging drugs and companies, visit <\/span><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/dermatomycoses-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Dermatomycoses Treatment Drugs<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Table of Contents<\/strong><\/p>\n<div style=\"text-align: justify;\" dir=\"ltr\" align=\"left\">\n<table>\n<colgroup>\n<col width=\"66\" \/>\n<col width=\"558\" \/><\/colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\"><span>1.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Key insights<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>2.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Executive Summary of Dermatomycoses<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>3.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Dermatomycoses: Market Overview at a Glance<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>4.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Disease Background and Overview: Dermatomycoses<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>5.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Dermatomycoses<\/span><span>Patient Journey<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>6.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Dermatomycoses Epidemiology and Patient Population&nbsp;&nbsp;<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>7.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Dermatomycoses: Country-Wise Epidemiology<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>8.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Dermatomycoses Treatment &amp; Medical Practices<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>9.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Dermatomycoses Marketed Products<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>10.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Dermatomycoses Emerging Therapies<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>11.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Dermatomycoses Pipeline Profiles<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>12.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Dermatomycoses: Market Size<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>13.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>7MM Dermatomycoses: Country-Wise Market Analysis<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>14.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Dermatomycoses Market Drivers<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>15.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Dermatomycoses Market Barriers<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>16.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>SWOT Analysis<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>17.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>KOL Views<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>18.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Dermatomycoses Reimbursement and market access<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>19.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Appendix<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>20.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>DelveInsight Capabilities<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>21.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>Disclaimer<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\"><span>22.<\/span><\/p>\n<\/td>\n<td>\n<p dir=\"ltr\"><span>About DelveInsight<\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>For rich insights into Healthcare and Pharmaceutical News, visit <\/span><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Pharma, Healthcare, and Biotech Blog Posts<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Related Reports<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/athletes-foot-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Athlete&rsquo;s Foot Market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>Get comprehensive historical and forecast analysis of <\/span><span>Athlete&rsquo;s Foot<\/span><span> Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as <\/span><span>Bausch Health, Dembiont, Blueberry Therapeutics, Novan,<\/span><span> among others.<\/span><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>About DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><span>DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.<\/span><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com\/_57048.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Sandeep Joshi<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=dermatomycoses-market-analysis-portrays-a-promising-outlook-of-the-emerging-drugs-during-the-forecast-period-202130\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> NV<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=dermatomycoses-market-analysis-portrays-a-promising-outlook-of-the-emerging-drugs-during-the-forecast-period-202130\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dermatomycoses Market Increased awareness of this distinct histology has resulted in the development of drugs specific to dermatomycoses, as well as the beginning of shedding light on the similarities and potential differences. DelveInsight&#8217;s Dermatomycoses market report provides a comprehensive understanding &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/dermatomycoses-market-analysis-portrays-a-promising-outlook-of-the-emerging-drugs-during-the-forecast-period-202130_555233.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,420,403,404],"tags":[],"class_list":["post-555233","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Science","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/555233","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=555233"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/555233\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=555233"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=555233"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=555233"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}